amfAR study observes potential breakthrough in treatment of HIV

SAN FRANCISCO – A new study funded by amfAR, The Foundation for AIDS Research conducted by researchers at the San Francisco VA Medical Center (SFVAMC) observes that pharmacological enhancement of the immune systems of HIV patients could help eliminate infected cells, providing an important step in the ongoing quest to find a lasting HIV cure….

Read More

GLAAD and The Elizabeth Taylor AIDS Foundation release new HIV and AIDS PSA (VIDEO)

NEW YORK, NY – GLAAD today announced the release of a Public Service Announcement (PSA) in partnership with The Elizabeth Taylor AIDS Foundation (ETAF). The PSA, produced by award-winning Martian Entertainment and airing exclusively on national LGBT cable channel Logo, was created to inspire, inform, and reignite the passion needed to beat the HIV and…

Read More

CytoDyn initiates Phase 3 Monotherapy Trial for HIV patients

VANCOUVER, Wash.– CytoDyn Inc. (OTC.QB:CYDY), a biotechnology company focused on the development of new antibody therapies for combating human immunodeficiency virus (HIV) infection, recently announced that it submitted a Phase 3 protocol for a monotherapy trial, along with the Topline Report for its Phase 2b monotherapy trial to the U.S. Food and Drug Administration (FDA). …

Read More

New research findings reveal health benefits of targeted case management for people living with HIV

New York, NY – Providing comprehensive, holistic case management to people dealing with multiple comorbid conditions, including HIV, can yield tangible health improvements and long-term cost savings, according to a new study released by Amida Care, a New York City nonprofit health plan, and ACRIA, an HIV/AIDS research organization. The report, “The Impact of Comprehensive…

Read More

CDC: Half of black gay men and a quarter of Latino gay men projected to be diagnosed with HIV within their lifetime

If current HIV diagnoses rates persist, about 1 in 2 black men who have sex with men (MSM) and 1 in 4 Latino MSM in the United States will be diagnosed with HIV during their lifetime, according to a new analysis by researchers at the Centers for Disease Control and Prevention (CDC). The study, presented…

Read More

Martin Shkreli invokes the Fifth Amendment and refuses to testify at House hearing

WASHINGTON — Today, the public got a disturbing window into the actions of former Turing Pharmaceuticals CEO Martin Shkreli, a sniggering, contemptuous former hedge fund manager who led a scheme to turn a profit off of price hikes on a crucial life-saving drug. At a House Oversight and Government Reform Committee hearing this morning, Shkreli…

Read More

Release of internal documents show greed driving Shkreli’s push for Turing’s massive price increase for Daraprim

Today the House Oversight Committee released a series of astonishing internal documents revealing the greed behind former Turing Pharmaceuticals CEO Martin Shkreli’s decision to increase by 5,000 percent the cost of the life-saving drug Daraprim. Daraprim is a crucial treatment for many pregnant women and people living with HIV. Last fall, then-Turing CEO Martin Shkreli…

Read More